Resection for esophageal carcinoma at a Virginia hospital 1981-1989.

P. D. Kiernan; M. J. Sheridan; W. D. Byrne; T. M. Fulcher; J. Conte; P. C. Corcoran; F. Pagani; L. Seigel

Resection for esophageal carcinoma at a Virginia hospital 1981-1989.

P. D. Kiernan, M. J. Sheridan, W. D. Byrne, T. M. Fulcher, J. Conte, P. C. Corcoran, F. Pagani, L. Seigel

Department of Surgery

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Between January 1, 1981 and December 31, 1989, 222 patients with carcinoma of the esophagus were seen at Fairfax Hospital. Fifty-eight (26.1%) underwent esophagogastrectomy. Operative (30-day) mortality was 8.6%. Follow-up was 98.3% complete. Of hospital survivors, 38 (76%) were resected for potential cure versus 12 (24%) for palliation. Consistent with the experience of others, a minority of patients (26%) presented with early (Stage I & II) disease; forty patients (69%) were noted to be Stage III or IV at time of resection and three patients (5%) were stage indeterminant. The five year Kaplan-Meier product limit survival estimate for Stage II patients was 52%, versus 22% for stage III, and 0% for Stage IV.

Original language	English (US)
Pages (from-to)	33-36
Number of pages	4
Journal	Virginia medical quarterly : VMQ
Volume	120
Issue number	1
State	Published - 1993

All Science Journal Classification (ASJC) codes

Medicine(all)

Cite this

@article{4bb52b150a404167ac2f08e94daa615c,

title = "Resection for esophageal carcinoma at a Virginia hospital 1981-1989.",

abstract = "Between January 1, 1981 and December 31, 1989, 222 patients with carcinoma of the esophagus were seen at Fairfax Hospital. Fifty-eight (26.1%) underwent esophagogastrectomy. Operative (30-day) mortality was 8.6%. Follow-up was 98.3% complete. Of hospital survivors, 38 (76%) were resected for potential cure versus 12 (24%) for palliation. Consistent with the experience of others, a minority of patients (26%) presented with early (Stage I & II) disease; forty patients (69%) were noted to be Stage III or IV at time of resection and three patients (5%) were stage indeterminant. The five year Kaplan-Meier product limit survival estimate for Stage II patients was 52%, versus 22% for stage III, and 0% for Stage IV.",

author = "Kiernan, {P. D.} and Sheridan, {M. J.} and Byrne, {W. D.} and Fulcher, {T. M.} and J. Conte and Corcoran, {P. C.} and F. Pagani and L. Seigel",

year = "1993",

language = "English (US)",

volume = "120",

pages = "33--36",

journal = "Virginia medical quarterly : VMQ",

issn = "1052-4231",

publisher = "Medical Society of Virginia",

number = "1",

}

TY - JOUR

T1 - Resection for esophageal carcinoma at a Virginia hospital 1981-1989.

AU - Kiernan, P. D.

AU - Sheridan, M. J.

AU - Byrne, W. D.

AU - Fulcher, T. M.

AU - Conte, J.

AU - Corcoran, P. C.

AU - Pagani, F.

AU - Seigel, L.

PY - 1993

Y1 - 1993

N2 - Between January 1, 1981 and December 31, 1989, 222 patients with carcinoma of the esophagus were seen at Fairfax Hospital. Fifty-eight (26.1%) underwent esophagogastrectomy. Operative (30-day) mortality was 8.6%. Follow-up was 98.3% complete. Of hospital survivors, 38 (76%) were resected for potential cure versus 12 (24%) for palliation. Consistent with the experience of others, a minority of patients (26%) presented with early (Stage I & II) disease; forty patients (69%) were noted to be Stage III or IV at time of resection and three patients (5%) were stage indeterminant. The five year Kaplan-Meier product limit survival estimate for Stage II patients was 52%, versus 22% for stage III, and 0% for Stage IV.

AB - Between January 1, 1981 and December 31, 1989, 222 patients with carcinoma of the esophagus were seen at Fairfax Hospital. Fifty-eight (26.1%) underwent esophagogastrectomy. Operative (30-day) mortality was 8.6%. Follow-up was 98.3% complete. Of hospital survivors, 38 (76%) were resected for potential cure versus 12 (24%) for palliation. Consistent with the experience of others, a minority of patients (26%) presented with early (Stage I & II) disease; forty patients (69%) were noted to be Stage III or IV at time of resection and three patients (5%) were stage indeterminant. The five year Kaplan-Meier product limit survival estimate for Stage II patients was 52%, versus 22% for stage III, and 0% for Stage IV.

UR - http://www.scopus.com/inward/record.url?scp=0027856780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027856780&partnerID=8YFLogxK

M3 - Article

C2 - 8420567

AN - SCOPUS:0027856780

SN - 1052-4231

VL - 120

SP - 33

EP - 36

JO - Virginia medical quarterly : VMQ

JF - Virginia medical quarterly : VMQ

IS - 1

ER -

Resection for esophageal carcinoma at a Virginia hospital 1981-1989.

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this